Stockreport

Mainz Biomed Provides Review of 2025 Highlights [Yahoo! Finance]

Mainz Biomed B.V.  (MYNZ) 
PDF Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer Project Study Demonstrated a Sensitivity of 100% and Specificity of 95% BERKELEY, Calif. and [Read more]